OLMA - Olema Pharmaceuticals GAAP EPS of -$0.82 misses by $0.18 August, 09 2022 05:27 PM Olema Pharmaceuticals Inc. Olema Pharmaceuticals press release ( NASDAQ: OLMA ): Q2 GAAP EPS of -$0.82 misses by $0.18 . Cash, cash equivalents and marketable securities as of June 30, 2022, were $240.7 million. For further details see: Olema Pharmaceuticals GAAP EPS of -$0.82 misses by $0.18